Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Oral thrush

Introduction

For patient information page on this topic, click here.

Synonyms and keywords: OPC; thrush; oral thrush; candidiasis of the mouth and throat; candidosis; oral moniliasis; oropharyngeal candidiasis

Overview

Overview

Oral candidiasis of the mouth and throat is a fungal infection that occurs when there is an overgrowth of candida. Candida yeasts normally live on the skin or mucous membranes in small amounts. However, if the environment inside the mouth or throat becomes imbalanced, the yeasts can multiply and cause symptoms. Candida overgrowth can also develop in the esophagus, and cause esophageal candidiasis.

Historical prespective

In 1839, B. Lagenbeck from Germany described a yeast-like fungus for the first time in the human oral infection thrush and its ability to cause it.

Pathophysiology

Candida species are normal inhabitants of the mouth, throat, and the rest of the gastrointestinal tract. Usually, candida yeasts live in and on the body in small amounts and do not cause any harm. However, the use of certain medications or immunosuppression can cause Candida to multiply, which may cause symptoms of infection.

Causes

Oral candidiasis is an infection of yeast fungus, Candida albicans, (or, less commonly, Candida glabrata or Candida tropicalis or C. parapsilosis or C. krusei or other candida species) in the mucous membranes of the mouth.

Differentiating oral candidiasis from other diseases

Oropharyngeal candidiasis must be differentiated from its different kinds and from various other diseases that can cause stomatitis or glossitisΨ²

Epidemiology and Demographics

Oral candidiasis is not common among the general population but is frequently diagnosed in the immunocompromised patients.

Risk Factors

People who have diabetes and had high blood sugar levels are more likely to get thrush in the mouth (oral thrush) because the extra sugar in saliva acts as a substrate for Candida. High doses of antibiotics or extended use of antibiotics also increases the risk of oral thrush. Antibiotics kill some of the healthy bacteria that help keep Candida from growing too much. People with poorly fitting dentures are also more likely to get thrush.

Natural History, Complications and Prognosis

There are no sequelae with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the mortality rate is almost 50%. Thrush in infants may be painful but is rarely serious. Because of discomfort, it can interfere with eating. If it does not resolve on its own within 2 weeks, a pediatrician should be notified. In adults, thrush that occurs in the mouth can be cured. However, the long-term outlook is dependent on immune status and the cause of the immune deficit.

In patients with a weakened immune system (for example, HIV-positive or receiving chemotherapy), Candida can spread throughout body, causing infection in esophagus (esophagitis), brain (meningitis), heart (endocarditis), joints (arthritis), or eyes (endophthalmitis).

Diagnosis

History and Symptoms

Adults may experience discomfort or burning in the mouth. Symptoms of candidiasis in the esophagus may include pain and dysphagia (difficult swallowing). Candida infections of the mouth and throat can manifest in a variety of ways. The most common symptom of oral thrush is white patches or plaques on the tongue and other oral mucous membranes.

Physical Examination

Oral infections of candida usually appear as thick white or cream color deposits. Underlying the deposits the mucosa of the mouth may appear inflamed (red and possibly slightly raised). Oral lesions are painless, white patches in the mouth.

Laboratory Findings

A healthcare provider diagnoses the infection based on symptoms, and by taking a scraping of affected areas to examine under a microscope. A culture may also be performed; however, because Candida organisms are normal inhabitants of the human mouth, a positive culture by itself does not make the diagnosis.

Treatment

Medical Therapy

Oral candidiasis can be treated with topical anti-fungal drugs, such as nystatin (Mycostatin), miconazole or amphotericin B. Patients who are immunocompromised, either with HIV/AIDS or as a result of chemotherapy, may require systemic treatment with oral or intravenous administered antifungals.

Primary Prevention

Good oral hygiene practices may help to prevent oral thrush in people with weakened immune systems. Some studies have shown that chlorhexidine (CHX) mouthwash can help to prevent oral candidiasis in people undergoing cancer treatment. People who use inhaled corticosteroids may be able to reduce the risk of developing thrush by washing out the mouth with water or mouthwash after using an inhaler.

Secondary prevention

Candida is usually a self-limiting disease unless concurrent immunosuppression is present.

References

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Historical Perspective

Overview

In 1839, B. Lagenbeck from Germany described a yeast-like fungus for the first time in the human oral infection thrush and its ability to cause it.

Historical Perspective

References

  1. ↑ Barnett JA (2008). “A history of research on yeasts 12: medical yeasts part 1, Candida albicans”. Yeast. 25 (6): 385–417. doi:10.1002/yea.1595. PMIDΒ 18509848.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2], Aravind Kuchkuntla, M.B.B.S[3], Ahmed Younes M.B.B.CH [4]

Pathophysiology

Overview

Candida is a normal commensal of the skin and mucous membranes. The balance between the virulence of the fungus and the host immune defense is responsible avoiding opportunistic infection of candida. Deficiency of cell-mediated immunity or poor general status are the main risk factors for having opportunistic candidiasis. Candidiasis is usually localized to skin and mucous membranes. In rare cases, candidiasis can spread causing candidemia and distant infection. These cases are usually associated with deficient immunity . C. albicans is the main species causing infection in humans more than any other candida species.

Pathophysiology

Pathogenesis

Candida is a normal commensal of skin and mucous membranes. A competent immune system and an intact regenerating healthy skin prevent the virulence of Candida.

Candida Virulence factors

The main virulence factors that mediate the infection:[1]

Any condition that compromises cell-mediated immunity, worsens the general status of the patient or provide a favorable medium for Candida to form biofilms put the patient at increased risk for having candidiasis.[2]

Candidal gene VPS4 plays an important role in mucosal candidiasis specifically. Moreover, fungi with mutations affecting this gene were found to be less virulent.[3][4]

Gross Pathology

Pseudomembranous candidiasis:

On speculum examination typical curdy white discharge is present. Usually present in newborns or in patients with deficient immunity, administering corticosteroids, etc.

Atrophic candidiasis:

Appears as erythema or edema without the characteristic white plaques. Usually, seen in patients with dental dentures.[5]

Chronic hyperplastic candidiasis (Candidal leukoplakia):

Persistent tough, adherent, white lesions that are indistinguishable from other leukoplakia except through biopsy. Seen more in smokers, patients with iron deficiency anemia or deficient cell-mediated immunity.[6][5]

Chronic mucocutaneous candidiasis (CMCC):

Microscopic pathology:

Candida albicans – By Y tambe – Y tambe’s file, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=233284

`

  • Microscopic examination of the wet mount with 10% KOH or saline demonstrates hyphae, pseudohyphae, and blastospores.

Videos

{{#ev:youtube|Qqb6vZtXxu8}}

References

  1. ↑ Mayer FL, Wilson D, Hube B (2013). “Candida albicans pathogenicity mechanisms”. Virulence. 4 (2): 119–28. doi:10.4161/viru.22913. PMCΒ 3654610. PMIDΒ 23302789.
  2. ↑ Pappas PG (2006). “Invasive candidiasis”. Infect. Dis. Clin. North Am. 20 (3): 485–506. doi:10.1016/j.idc.2006.07.004. PMIDΒ 16984866.
  3. ↑ Rane HS, Hardison S, Botelho C, Bernardo SM, Wormley F, Lee SA (2014). “Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis”. Virulence. 5 (8): 810–8. doi:10.4161/21505594.2014.956648. PMIDΒ 25483774.
  4. ↑ Lee SA, Jones J, Hardison S, Kot J, Khalique Z, Bernardo SM, Lazzell A, Monteagudo C, Lopez-Ribot J (2009). “Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence”. Mycopathologia. 167 (2): 55–63. doi:10.1007/s11046-008-9155-7. PMIDΒ 18814053.
  5. ↑ 5.0 5.1 Lynch DP (1994). “Oral candidiasis. History, classification, and clinical presentation”. Oral Surg. Oral Med. Oral Pathol. 78 (2): 189–93. PMIDΒ 7936588.
  6. ↑ “CHRONIC HYPERPLASTTC CANDIDIASISβ€”CANDIDAL LEUKOPLAKIA – CAWSON – 1968 – British Journal of Dermatology – Wiley Online Library”.
  7. ↑ Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL (2011). “Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity”. Science. 332 (6025): 65–8. doi:10.1126/science.1200439. PMCΒ 3070042. PMIDΒ 21350122.
  8. ↑ Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, Ring J, Traidl-Hoffmann C (2008). “Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22”. J. Invest. Dermatol. 128 (11): 2640–5. doi:10.1038/jid.2008.139. PMIDΒ 18615114.
  9. ↑ “Public Health Image Library (PHIL)”.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Causes

Overview

C. albicansΒ is the main species causing infection in humans more than any other candida species.

Causes:

Most common causes:

Candida albicans is the most common cause of oropharyngeal candidiasis.[1][2]

Less common causes:

Other candida strains can cause oropharyngeal candidiasis:[1][2]

References

  1. ↑ 1.0 1.1 Barchiesi F, Morbiducci V, Ancarani F, Scalise G (1993). “Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients”. Eur. J. Epidemiol. 9 (4): 455–6. PMIDΒ 8243605.
  2. ↑ 2.0 2.1 Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA (1994). “Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance”. Am. J. Med. 97 (4): 339–46. PMIDΒ 7942935.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Differentiating Oral Candidiasis from other Diseases

Overview

Oropharyngeal candidiasis must be differentiated from its different kinds and from various other diseases that can cause stomatitis or glossitis

Differential diagnosis

Oropharyngeal candidiasis must be differentiated from its different kinds and from various other diseases that can cause stomatitis or glossitis:[1][2]

Oral candidiasis must be differentiated from other diseases causing oral lesions such as leukoplakia and herpes simplex virus infection.

Disease Presentation Risk Factors Diagnosis Affected Organ Systems Important features Picture
Diseases predominantly affecting the oral cavity
Oral Candidiasis
  • Denture users
  • As a side effect of medication, most commonly having taken antibiotics. Inhaled corticosteroids for the treatment of lung conditions (e.g, asthma or COPD) may also result in oral candidiasis which may be reduced by regularly rinsing the mouth with water after taking the medication.
  • Clinical diagnosis
  • Confirmatory tests rarely needed
Localized candidiasis

Invasive candidasis

Tongue infected with oral candidiasis – By James Heilman, MD – Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=11717223.jpg
Herpes simplex oral lesions
  • Stress
  • Recent URTI
  • Female sex
  • The symptoms of primary HSV infection generally resolve within two weeks
Oral herpes simplex infection – By James Heilman, MD – Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=19051042.jpg
Aphthous ulcers
  • Painful, red spot or bump that develops into an open ulcer
  • Physical examination
  • Diagnosis of exclusion
  • Oral cavity
  • Self-limiting , Pain decreases in 7 to 10 days, with complete healing in 1 to 3 weeks
By Ebarruda – Own work, CC BY-SA 3.0, httpscommons.wikimedia.orgwindex.phpcurid=7903358
Squamous cell carcinoma
Squamous cell carcinoma – By Luca Pastore, Maria Luisa Fiorella, Raffaele Fiorella, Lorenzo Lo Muzio – http://www.plosmedicine.org/article/showImageLarge.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.0050212.g001, CC BY 2.5, https://commons.wikimedia.org/w/index.php?curid=15252632
Leukoplakia
  • Vulvar lesions occur independent of oral lesions
Leukoplakia – By Aitor III – Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=9873087
Melanoma
Oral melanoma – By Emmanouil K Symvoulakis, Dionysios E Kyrmizakis, Emmanouil I Drivas, Anastassios V Koutsopoulos, Stylianos G Malandrakis, Charalambos E Skoulakis and John G Bizakis – Symvoulakis et al. Head & Face Medicine 2006 2:7 doi:10.1186/1746-160X-2-7 (Open Access), [1], CC BY-SA 2.0, https://commons.wikimedia.org/w/index.php?curid=9839811
Fordyce spots
Fordyce spots – Por Perene – Obra do prΓ³prio, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=19772899
Burning mouth syndrome
Torus palatinus
Torus palatinus – By Photo taken by dozenist, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=846591
Diseases involving oral cavity and other organ systems
Behcet’s disease
Behcet’s disease – By Ahmet Altiner MD, Rajni Mandal MD – http://dermatology.cdlib.org/1611/articles/18_2009-10-20/2.jpg, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=17863021
Crohn’s disease
Agranulocytosis
Syphilis[11]
oral syphilis – By CDC/Susan Lindsley – http://phil.cdc.gov/phil_images/20021114/34/PHIL_2385_lores.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=2134349
Coxsackie virus
  • Symptomatic treatment
Hand-foot-and-mouth disease
Chicken pox
Chickenpox – By James Heilman, MD – Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=52872565
Measles
  • Unvaccinated individuals[12][13]
  • Crowded and/or unsanitary conditions
  • Traveling to less developed and developing countries
  • Immunocompromized
  • Winter and spring seasons
  • Born after 1956 and never fully vaccinated
  • Health care workers
Koplick spots (Measles) – By CDC – http://phil.cdc.gov/PHIL_Images/20040908/4f54ee8f0e5f49f58aaa30c1bc6413ba/6111_lores.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=824483

References

  1. ↑ Mandell; Gouglas, Gordon; Bennett, John. Principles and Practice of Infectious Diseases. Harvard Medical School: WILEY MEDICAL. p.Β 383. ISBNΒ 0-471-87643-7. Unknown parameter |firs1t= ignored (help)​
  2. ↑ Scully C (1999). “A review of common mucocutaneous disorders affecting the mouth and lips”. Ann Acad Med Singapore. 28 (5): 704–7. PMIDΒ 10597357.
  3. ↑ R. Morgan, J. Tsang, N. Harrington & L. Fook (2001). “Survey of hospital doctors’ attitudes and knowledge of oral conditions in older patients”. Postgraduate medical journal. 77 (908): 392–394. PMIDΒ 11375454. Unknown parameter |month= ignored (help)
  4. ↑ D. Grady, J. Greene, T. E. Daniels, V. L. Ernster, P. B. Robertson, W. Hauck, D. Greenspan, J. Greenspan & S. Jr Silverman (1990). “Oral mucosal lesions found in smokeless tobacco users”. Journal of the American Dental Association (1939). 121 (1): 117–123. PMIDΒ 2370378. Unknown parameter |month= ignored (help)
  5. ↑ P. DeMatos, D. S. Tyler & H. F. Seigler (1998). “Malignant melanoma of the mucous membranes: a review of 119 cases”. Annals of surgical oncology. 5 (8): 733–742. PMIDΒ 9869521. Unknown parameter |month= ignored (help)
  6. ↑ Barry Ladizinski & Kachiu C. Lee (2014). “A nodular protuberance on the hard palate”. JAMA. 311 (15): 1558–1559. doi:10.1001/jama.2014.271. PMIDΒ 24737369. Unknown parameter |month= ignored (help)
  7. ↑ Magliocca KR, Fitzpatrick SG (2017) Autoimmune Disease Manifestations in the Oral Cavity. Surg Pathol Clin 10 (1):57-88. DOI:10.1016/j.path.2016.11.001 PMID: 28153136
  8. ↑ Dalghous AM, Freysdottir J, Fortune F (2006). “Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet’s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD”. Scand J Rheumatol. 35 (6): 472–5. PMIDΒ 17343257.
  9. ↑ Ann M. Gillenwater, Nadarajah Vigneswaran, Hanadi Fatani, Pierre Saintigny & Adel K. El-Naggar (2013). “Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!”. Advances in anatomic pathology. 20 (6): 416–423. doi:10.1097/PAP.0b013e3182a92df1. PMIDΒ 24113312. Unknown parameter |month= ignored (help)
  10. ↑ AndrΓ¨s E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). “Idiosyncratic drug-induced agranulocytosis: Update of an old disorder”. Eur J Intern Med. 17 (8): 529–35. Text “pmid 17142169” ignored (help)
  11. ↑ title=”By Internet Archive Book Images [No restrictions], via Wikimedia Commons” href=”https://commons.wikimedia.org/wiki/File:A_manual_of_syphilis_and_the_venereal_diseases%2C_(1900)_(14595882378).jpg“
  12. ↑ Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE (2000). “Individual and community risks of measles and pertussis associated with personal exemptions to immunization”. JAMA. 284 (24): 3145–50. PMIDΒ 11135778.
  13. ↑ Ratnam S, West R, Gadag V, Williams B, Oates E (1996). “Immunity against measles in school-aged children: implications for measles revaccination strategies”. Can J Public Health. 87 (6): 407–10. PMIDΒ 9009400.

|}|}|}|}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Epidemiology and Demographics

Overview

Oral candidiasis is not common among the general population but is frequently diagnosed in the immunocompromised patients.

Epidemiology and Demographics

  • The infection is not very common in the general population.
  • It is estimated that between 5% and 7% of infants less than one month old will develop oral candidiasis.
  • The prevalence of oral candidiasis among AIDS patients is estimated to be between 9% and 31%, and studies have documented clinical evidence of oral candidiasis in nearly 20% of cancer patients.[1]
  • Thrush is the fourth most common cause of nosocomial bloodstream infections.
  • The incidence is 8 cases per 100,000 in the general population.
  • There is a higher incidence among neonates and African-Americans.[2]
  • Oleander (OPC) used to be a common opportunistic infection in HIV-infected persons (prior to the introduction of highly active antiretroviral therapy HAART).
  • Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites.[3]

References

  1. ↑ Daniluk T, Tokajuk G, Stokowska W, Fiedoruk K, Sciepuk M, Zaremba ML, Rozkiewicz D, Cylwik-Rokicka D, Kedra BA, Anielska I, GΓ³rska M, Kedra BR (2006). “Occurrence rate of oral Candida albicans in denture wearer patients”. Adv Med Sci. 51 Suppl 1: 77–80. PMIDΒ 17458064.
  2. ↑ Campisi G, Pizzo G, Milici ME, Mancuso S, Margiotta V (2002). “Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects”. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 93 (3): 281–6. PMIDΒ 11925537.
  3. ↑ Reichart PA (2003). “Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi’s sarcoma”. Med. Microbiol. Immunol. 192 (3): 165–9. doi:10.1007/s00430-002-0175-5. PMIDΒ 12684760.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Risk Factors

Overview

Uncontrolled diabetes are more likely to get oral thrush, because the extra glucose in saliva acts as a substrate for Candida. High doses of antibiotics or extended use of antibiotics also increases the risk of oral thrush. Antibiotics kill bacterial flora that compete with candida. People with poorly fitting dentures are also more likely to get thrush.

Risk Factors

At Risk Individuals[1]

References

  1. ↑ Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016). “Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America”. Clin. Infect. Dis. 62 (4): e1–50. doi:10.1093/cid/civ933. PMCΒ 4725385. PMIDΒ 26679628.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Natural History, Complications and Prognosis

Overview

There are no sequelae with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the morbidity and mortality are very high.

Natural history

Complications

Oropharyngeal candidiasis is rarely complicated except in immunocompromised individuals.

Prognosis

  • Prognosis of oropharyngeal candidiasis is excellent in otherwise immunocompetent individuals with no serious sequelae in the majority of cases.
  • Special attention should be given to immunocompromised patients as local spread to the trachea or esophagus or systemic spread causing candidaemia or distant candidiasis can be very serious with very high mortality rate.

References

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:Mycoses

da:TrΓΈske (infektion) it:Mughetto (malattia)


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S